NCT00001328View on ClinicalTrials.gov

Gene Therapy for the Treatment of Brain Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

August 21, 1992

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Brain NeoplasmNeoplasm Metastasis
Interventions
DRUG

Cytovene (Ganciclovir Sodium)

DEVICE

G1TKSVNa.53 Producer Cell Line

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT00001328 - Gene Therapy for the Treatment of Brain Tumors | Biotech Hunter | Biotech Hunter